HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

Hydrochloric Acid → 4-Vinylsulfonyl-morpholine

HRID 272548
Print

Reaction equation

HRID 272548 reaction equation
C1C2[C:10]3=[CH:12]C4C=CC(C(N)=O)=[CH:17][C:18]=4[N:9]3CC=CC=2C=CC=1.C1C2C3=CC4C=C[C:37]([C:40](O)=O)=CC=4N3CC=CC=2C=CC=1.[OH-:43].[Na+].Cl.C(Cl)(=O)C(Cl)=O.CCN(P1(N(C)CCCN1C)=NC(C)(C)C)CC.CN[S:72](NC)(=[O:74])=[O:73]>C(Cl)Cl.CO.C1COCC1>[CH:37]([S:72]([N:9]1[CH2:10][CH2:12][O:43][CH2:17][CH2:18]1)(=[O:74])=[O:73])=[CH2:40]
ParticipantsConditionsProcedureWorkupSources & evidenceReaction notes

Participants

10

Reactant 7

HCID 313Hydrochloric Acid2×HCID 14798Sodium HydroxideHCID 65578Oxalyl chlorideHCID 89736N,N'-DimethylsulfamideHCID 35138512-((1,1-Dimethylethyl)imino)-N,N-diethylhexahydro-1,3-dimethyl-2lambda5-1,3,2-diazaphosphorin-2-amineHCID 666396797H-indolo[2,1-a][2]benzazepine-10-carboxylic acid
HCID 666396907H-indolo[2,1-a][2]benzazepine-10-carboxamide

Product 1

HCID 159145184-Vinylsulfonyl-morpholineYield 71%

Reagents, catalysts & solvents 2

HCID 6344DichloromethaneSolvent2×HCID 21899815MeOH tetrahydrofuranSolvent

Conditions

Temperature
22 °C

Procedure

7H-Indolo[2,1-a][2]benzazepine-10-carboxamide, 13-cyclohexyl-N-[(dimethylamino)sulfonyl]-3-methoxy-6-(4-morpholinylsulfonyl)-. To a solution of 7H-Indolo[2,1-a][2]benzazepine-10-carboxylic acid, 13-cyclohexyl-3-methoxy-6-(4-morpholinylsulfonyl)-, methyl ester (60 mg, 0.11 mmol) in 1:1 MeOH/THF (2.0 mL) was added 1M NaOH (2.0 mL). The resulting mixture was stirred at 22° C. for 16 hr. 1M HCl (15 mL) was added and the aqueous layer was extracted with CHCl3 (2×15 mL). The organic phase was dried over Na2SO4, filtered, and concentrated under reduced pressure to afford a white solid. This solid was dissolved in CH2Cl2 (1.0 mL) and 2M oxalyl chloride (1.0 mL) in CH2Cl2 was added. This solution was stirred at 22° C. for 2 hr and concentrated under reduced pressure. The resulting yellow oil was redissolved in CH2Cl2 (1.0 mL); BEMP (60 mg, 0.22 mmol) and dimethylsulfamide (68 mg, 0.55 mmol) were added. The resulting mixture was allowed to stir at 22° C. for 6 hr. 1M HCl (15 mL) was added and the aqueous layer was extracted with CHCl3 (2×30 mL). The organic phase was concentrated under reduced pressure. This oil was purified by reverse-phase prep HPLC to afford the title compound (50 mg, 71%) as a yellow paste. MS 643 m/z (MH+). 1H NMR (300 MHz, CDCl3) δ ppm 1.15-1.60 (m, 4H), 1.80 (m, 1H), 1.91-2.12 (m, 5H), 2.81 (m, 3H), 3.08 (broad s, 8H), 3.22 (m, 2H), 3.41 (m, 2H), 3.92 (s, 3H), 4.4 (broad d, 1H), 5.36 (broad d, 1H), 7.02 (d, 1H), 7.15 (m, 1H), 7.40 (m, 1H), 7.51 (m, 1H), 7.68 (s, 1H), 7.90 (m, 1H), 8.11 (s, 1H), 8.58 (s, 1H).

Workup

  1. extractionthe aqueous layer was extracted with CHCl3 (2×15 mL)
  2. dry with materialThe organic phase was dried over Na2SO4
  3. filtrationfiltered
  4. concentrationconcentrated under reduced pressure
  5. customto afford a white solid
  6. stirringThis solution was stirred at 22° C. for 2 hr
  7. concentrationconcentrated under reduced pressure
  8. dissolutionThe resulting yellow oil was redissolved in CH2Cl2 (1.0 mL)
  9. stirringto stir at 22° C. for 6 hr
  10. extractionthe aqueous layer was extracted with CHCl3 (2×30 mL)
  11. concentrationThe organic phase was concentrated under reduced pressure
  12. customThis oil was purified by reverse-phase prep HPLC

Sources & evidence

ORD record
ord-9005c5b5ea0849baadd1aedd86b42931
Source dataset
uspto-grants-2008_11
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US07456167B2

Reaction notes

On this pageParticipantsConditionsProcedureWorkupSources & evidenceReaction notes